EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
6.1.1.17 | Down Syndrome |
14757529 |
Regulation of glutamate receptor RNA editing and ADAR mRNA expression in developing human normal and Down's syndrome brains. |
causal interaction ongoing research unassigned |
1 1 0 |
6.1.1.17 | Drug Resistant Epilepsy |
28056632 |
Case Report. |
causal interaction unassigned |
4 0 |
6.1.1.17 | Epilepsy |
10805145 |
Potential target sites in peripheral tissues for excitatory neurotransmission and excitotoxicity. |
causal interaction unassigned |
4 0 |
6.1.1.17 | Epilepsy |
22069702 |
Effects of Spider Venom Toxin PWTX-I (6-Hydroxytrypargine) on the Central Nervous System of Rats. |
unassigned |
0 |
6.1.1.17 | Epilepsy |
28620870 |
Severe growth deficiency, microcephaly, intellectual disability, and characteristic facial features are due to a homozygous QARS mutation. |
causal interaction diagnostic usage unassigned |
4 3 0 |
6.1.1.17 | Epilepsy |
32561150 |
Dual-Targeted Autoimmune Sword in Fatal Epilepsy: Patient's glutamate receptor AMPA GluR3B peptide autoimmune antibodies bind, induce Reactive Oxygen Species (ROS) in, and kill both human neural cells and T cells. |
diagnostic usage unassigned |
3 0 |
6.1.1.17 | Glaucoma |
15111612 |
Acetylcholine protection of adult pig retinal ganglion cells from glutamate-induced excitotoxicity. |
therapeutic application unassigned |
1 0 |
6.1.1.17 | Glaucoma |
16273539 |
Factors contributing to neuronal degeneration in retinas of experimental glaucomatous rats. |
causal interaction therapeutic application unassigned |
1 1 0 |
6.1.1.17 | glutamate-trna ligase deficiency |
28056632 |
Case Report. |
causal interaction unassigned |
4 0 |
6.1.1.17 | glutamate-trna ligase deficiency |
28620870 |
Severe growth deficiency, microcephaly, intellectual disability, and characteristic facial features are due to a homozygous QARS mutation. |
causal interaction diagnostic usage unassigned |
4 3 0 |